Development Partners for BioPharma
Your current contract laboratory and instrument provider may be familiar and comfortable, but, maintaining the status quo doesn’t lead to greater rewards. In fact, it often involves putting up with less-than-desired results. Join us in this executive summary to hear how Ajinomoto Althea develops unsurpassed solutions for biopharma companies, and how a team at Thermo Fisher Scientific has challenged the status quo to deliver uncompromised UHPLC.
Recent Videos
Speaking to Future Analytical Chemists: An Interview with Vilmos Kertesz
Honoring Mentors: An Interview with Vilmos Kertesz
Developing and Commercializing Liquid Extraction Techniques: An Interview with Vilmos Kertesz
Reflecting on Research: An Interview with Vilmos Kertesz
Slalom Chromatography Revisited (Part 2); An Interview with Fabrice Gritti
Previewing ASMS 2025: An Interview with Vilmos Kertesz
Slalom Chromatography Revisited (Part 1): An Interview With Fabrice Gritti
A Message to the Next Generation: An Interview with Michael Shortreed
Influencing Software and Reflecting on Mentors: An Interview with Michael Shortreed
The Path to the Al Yergey MS Scientist Award: An Interview with Michael Shortreed
Related Content
Characterizing Polyamides Using Reversed-Phase Liquid Chromatography
May 5th 2025Article
Polyamides can be difficult to characterize, despite their use in various aspects of everyday life. Vrije Universiteit Amsterdam researchers hoped to address this using a reversed-phase liquid chromatography (RPLC)-based approach.
